Melatonin reduces the severity of anesthesia-induced apoptotic neurodegeneration in the developing rat brain

Jun Heum Yon, Lisa B. Carter, Russel J Reiter, Vesna Jevtovic-Todorovic

Research output: Contribution to journalArticle

153 Citations (Scopus)

Abstract

General anesthetics cause widespread apoptotic neurodegeneration in many regions of the developing rat brain. The activation of mitochondria-dependent apoptotic pathway is important in the early stages of anesthesia-induced developmental neuroapoptosis. To investigate potential means of protecting against this type of damage, we studied melatonin, a sleep-promoting agent and antioxidant known to inhibit apoptotic-type neuronal damage by improving mitochondrial homeostasis and stabilizing the inner mitochondrial membrane. When 7-day-old rats (the peak of synaptogenesis) were exposed to a commonly used and highly pro-apoptotic anesthesia cocktail (midazolam, isoflurane, nitrous oxide) in combination with the escalating doses of melatonin (from 1 to 20 mg/kg, s.c.), the severity of anesthesia-induced damage was reduced in a dose-dependent manner in two most vulnerable brain regions-the cerebral cortex and anterior thalamus. Melatonin-induced neuroprotection was mediated, at least in part, via the inhibition of mitochondria-dependent apoptotic pathway since melatonin caused an up-regulation of the anti-apoptotic protein, bcl-XL, reduction in anesthesia-induced cytochrome c release into the cytoplasm and a decrease in anesthesia-induced activation of caspase-3, an important step in the activation of DNAses and the formation of the apoptotic bodies.

Original languageEnglish (US)
Pages (from-to)522-530
Number of pages9
JournalNeurobiology of Disease
Volume21
Issue number3
DOIs
StatePublished - Mar 2006

Fingerprint

Melatonin
Anesthesia
Brain
Mitochondria
Anterior Thalamic Nuclei
General Anesthetics
Apoptosis Regulatory Proteins
Deoxyribonucleases
Isoflurane
Midazolam
Nitrous Oxide
Mitochondrial Membranes
Cytochromes c
Caspase 3
Cerebral Cortex
Cytoplasm
Homeostasis
Up-Regulation
Antioxidants

Keywords

  • Apoptosis
  • bcl-2
  • Caspase
  • Cytochrome c
  • Mitochondria
  • Synaptogenesis

ASJC Scopus subject areas

  • Neurology

Cite this

Melatonin reduces the severity of anesthesia-induced apoptotic neurodegeneration in the developing rat brain. / Yon, Jun Heum; Carter, Lisa B.; Reiter, Russel J; Jevtovic-Todorovic, Vesna.

In: Neurobiology of Disease, Vol. 21, No. 3, 03.2006, p. 522-530.

Research output: Contribution to journalArticle

Yon, Jun Heum ; Carter, Lisa B. ; Reiter, Russel J ; Jevtovic-Todorovic, Vesna. / Melatonin reduces the severity of anesthesia-induced apoptotic neurodegeneration in the developing rat brain. In: Neurobiology of Disease. 2006 ; Vol. 21, No. 3. pp. 522-530.
@article{343fb3219d6a413aa536f0a0588b0b3d,
title = "Melatonin reduces the severity of anesthesia-induced apoptotic neurodegeneration in the developing rat brain",
abstract = "General anesthetics cause widespread apoptotic neurodegeneration in many regions of the developing rat brain. The activation of mitochondria-dependent apoptotic pathway is important in the early stages of anesthesia-induced developmental neuroapoptosis. To investigate potential means of protecting against this type of damage, we studied melatonin, a sleep-promoting agent and antioxidant known to inhibit apoptotic-type neuronal damage by improving mitochondrial homeostasis and stabilizing the inner mitochondrial membrane. When 7-day-old rats (the peak of synaptogenesis) were exposed to a commonly used and highly pro-apoptotic anesthesia cocktail (midazolam, isoflurane, nitrous oxide) in combination with the escalating doses of melatonin (from 1 to 20 mg/kg, s.c.), the severity of anesthesia-induced damage was reduced in a dose-dependent manner in two most vulnerable brain regions-the cerebral cortex and anterior thalamus. Melatonin-induced neuroprotection was mediated, at least in part, via the inhibition of mitochondria-dependent apoptotic pathway since melatonin caused an up-regulation of the anti-apoptotic protein, bcl-XL, reduction in anesthesia-induced cytochrome c release into the cytoplasm and a decrease in anesthesia-induced activation of caspase-3, an important step in the activation of DNAses and the formation of the apoptotic bodies.",
keywords = "Apoptosis, bcl-2, Caspase, Cytochrome c, Mitochondria, Synaptogenesis",
author = "Yon, {Jun Heum} and Carter, {Lisa B.} and Reiter, {Russel J} and Vesna Jevtovic-Todorovic",
year = "2006",
month = "3",
doi = "10.1016/j.nbd.2005.08.011",
language = "English (US)",
volume = "21",
pages = "522--530",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Melatonin reduces the severity of anesthesia-induced apoptotic neurodegeneration in the developing rat brain

AU - Yon, Jun Heum

AU - Carter, Lisa B.

AU - Reiter, Russel J

AU - Jevtovic-Todorovic, Vesna

PY - 2006/3

Y1 - 2006/3

N2 - General anesthetics cause widespread apoptotic neurodegeneration in many regions of the developing rat brain. The activation of mitochondria-dependent apoptotic pathway is important in the early stages of anesthesia-induced developmental neuroapoptosis. To investigate potential means of protecting against this type of damage, we studied melatonin, a sleep-promoting agent and antioxidant known to inhibit apoptotic-type neuronal damage by improving mitochondrial homeostasis and stabilizing the inner mitochondrial membrane. When 7-day-old rats (the peak of synaptogenesis) were exposed to a commonly used and highly pro-apoptotic anesthesia cocktail (midazolam, isoflurane, nitrous oxide) in combination with the escalating doses of melatonin (from 1 to 20 mg/kg, s.c.), the severity of anesthesia-induced damage was reduced in a dose-dependent manner in two most vulnerable brain regions-the cerebral cortex and anterior thalamus. Melatonin-induced neuroprotection was mediated, at least in part, via the inhibition of mitochondria-dependent apoptotic pathway since melatonin caused an up-regulation of the anti-apoptotic protein, bcl-XL, reduction in anesthesia-induced cytochrome c release into the cytoplasm and a decrease in anesthesia-induced activation of caspase-3, an important step in the activation of DNAses and the formation of the apoptotic bodies.

AB - General anesthetics cause widespread apoptotic neurodegeneration in many regions of the developing rat brain. The activation of mitochondria-dependent apoptotic pathway is important in the early stages of anesthesia-induced developmental neuroapoptosis. To investigate potential means of protecting against this type of damage, we studied melatonin, a sleep-promoting agent and antioxidant known to inhibit apoptotic-type neuronal damage by improving mitochondrial homeostasis and stabilizing the inner mitochondrial membrane. When 7-day-old rats (the peak of synaptogenesis) were exposed to a commonly used and highly pro-apoptotic anesthesia cocktail (midazolam, isoflurane, nitrous oxide) in combination with the escalating doses of melatonin (from 1 to 20 mg/kg, s.c.), the severity of anesthesia-induced damage was reduced in a dose-dependent manner in two most vulnerable brain regions-the cerebral cortex and anterior thalamus. Melatonin-induced neuroprotection was mediated, at least in part, via the inhibition of mitochondria-dependent apoptotic pathway since melatonin caused an up-regulation of the anti-apoptotic protein, bcl-XL, reduction in anesthesia-induced cytochrome c release into the cytoplasm and a decrease in anesthesia-induced activation of caspase-3, an important step in the activation of DNAses and the formation of the apoptotic bodies.

KW - Apoptosis

KW - bcl-2

KW - Caspase

KW - Cytochrome c

KW - Mitochondria

KW - Synaptogenesis

UR - http://www.scopus.com/inward/record.url?scp=33244492125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33244492125&partnerID=8YFLogxK

U2 - 10.1016/j.nbd.2005.08.011

DO - 10.1016/j.nbd.2005.08.011

M3 - Article

C2 - 16289675

AN - SCOPUS:33244492125

VL - 21

SP - 522

EP - 530

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

IS - 3

ER -